References
- Panjari M, Davis SR. DHEA for postmenopausal women: A review of the evidence? Maturitas 2010;Jan 18. Epub ahead of print
- Labrie F, Luu-The V, Bélanger A, et al Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169–196
- Davis SR, Davison SL, Donath S, et al Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–96
- Davis SR, Shah SM, McKenzie DP, et al Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 2008;93:801–808
- Genazzani AR, Pluchino N, Begliuomini S, et al Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol 2006;22:627–635
- Maninger N, Wolkowitz OM, Reus VI, et al Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009;30:65–91
- Simoncini T, Mannella P, Fornari L, et al Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 2003;144:3449–3455
- Labrie F, Archer D, Bouchard C, et al Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897–906
- Pluchino N, Ninni F, Stomati M, et al One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas 2008;59:293–303